Acta Diabetologica

, Volume 50, Issue 2, pp 123–128 | Cite as

Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery

  • M. A. M. Wit
  • M. de Mulder
  • E. K. Jansen
  • V. A. W. M. Umans
Original Article


Diabetes mellitus (DM) is an important risk factor for accelerated atherosclerosis and increases cardiovascular disease. Several studies found a higher mortality rate in postoperative diabetic patients than in non-diabetic patients. However, other studies found conflicting evidence on bypass graft dysfunction in patients with diabetes mellitus. We therefore investigated the influence of diabetes mellitus on the long-term outcome after coronary artery bypass surgery (CABG). In this prospective study, 936 consecutive CABG patients were included. These patients were divided into three groups: patients without diabetes mellitus, patients with diabetes mellitus using oral drugs (non-insulin-treated DM) and patients with diabetes mellitus using insulin (insulin-treated DM). The three groups were compared for mortality and (angiographic) bypass graft dysfunction. Of the 936 included patients, 720 (76.8%) patients were non-diabetics, 138 (14.7%) were non-insulin-treated DM, and 78 (8.3%) patients were insulin-treated DM. Follow-up was achieved in all patients, at a mean of 33 months. Mortality was significantly higher in patients with insulin-treated DM, compared with non-insulin-treated DM or non-diabetic patients (P = 0.003). Fourteen (1.5%) patients suffered a myocardial infarction after CABG. A coronary angiography was performed in 77 (8.2%) patients during follow-up, proven bypass graft dysfunction was found in 41 (53.2%) patients. There was no significant difference in bypass graft dysfunction between the three groups. Diabetes mellitus has a significant impact on long-term follow-up after coronary surgery. Particularly insulin dependency is related to an increased mortality. However, diabetes has no influence on angiographically proven bypass graft dysfunction.


Coronary artery bypass graft surgery Diabetes mellitus Mortality Bypass graft dysfunction 



The authors would like to acknowledge Sophie Umans for helping in data entry.


  1. 1.
    Mazzone T, Chait A, Pultzky J (2008) Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371:1800–1809PubMedCrossRefGoogle Scholar
  2. 2.
    Leavitt BJ (2007) The effects of diabetes mellitus on coronary artery bypass graft surgery. Curr Diab Rep 7:20–24PubMedCrossRefGoogle Scholar
  3. 3.
    Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton JH, Charlesworth DC, Weintraub RM, Hernandez F, Olmstead EM, Nugent WC, O’Connor GT, Ross CS (2004) Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 110(suppl II):II-41–44Google Scholar
  4. 4.
    Filsoufi F, Rahmanian PB, Castillo JG, Mechanick JI, Sharma SK, Adams DH (2007) Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 6:753–758PubMedCrossRefGoogle Scholar
  5. 5.
    Rajakaruna C, Rogers CA, Suranimala C, Angelini GD, Ascione R (2006) The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg 132:802–810PubMedCrossRefGoogle Scholar
  6. 6.
    Gitman MR, Okrainee K, Nguyen H, Duerr R, Del Cor M, Fourchy D, Huynh T, Lader E, Rogers FJ, Chaudry MR, Pilote L, Eisenberg MJ (2005) Impact of diabetes on 12 month outcomes following coronary artery bypass graft surgery: results from the ROSETTA-CABG registry. Can J Cardiol 21(13):1169–1174PubMedGoogle Scholar
  7. 7.
    Mohammadi S, Dagenais F, Mathieu P, Kingma JG, Doyle D, Lopez S, Baillot R, Perron J, Charbonneau E, Dumont E, Metras J, Desaulniers D, Voisine P (2007) Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation 116(11 suppl I):1-220–1-225Google Scholar
  8. 8.
    Mehran R, Dangas GD, Kobayashi Y, Lansky AJ, Mintz GS, Aymong ED, Fahy M, Moses JW, Stone GW, Leon MB (2004) Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol 43:1348–1354PubMedCrossRefGoogle Scholar
  9. 9.
    Baan CA, Schoemaker CG, Jacobs-van der Bruggen MAM, Hamberg-van Reenen HH, Verkleij H, Heus S, Melse JM (2009) Diabetes tot 2025. Preventie en zorg in samenhang. RIVM rapport 260322004.
  10. 10.
    Calafiore AM, Di Mauro M, Di Giammarco G, Contini M, Vitolla G, lacò AL, Canosa C, D’Alessandro S (2003) Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 125:144–154PubMedCrossRefGoogle Scholar
  11. 11.
    Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, Tryzelaar JF, Clough R, Hearne MJ, Hernandez F Jr, Watkins MW, Gerald T (2001) O’Connor for the Northern New England cardiovascular disease study group. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. J Am Coll Cardiol 37:1008–1015PubMedCrossRefGoogle Scholar
  12. 12.
    The BARI 2d study Group (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360:2503–2515CrossRefGoogle Scholar
  13. 13.
    Marcheix B, Eynden FV, Demers P, Bouchard D, Cartier R (2008) Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery. Ann Thorac Surg Assoc 86:1181–1188CrossRefGoogle Scholar
  14. 14.
    Cole JH, Jones EL, Craver JM, Craver JM, Guyton RA, Morris DC, Douglas JS Jr, Ghazzal Z, Weintraub WS (2002) Outcomes of repeat revascularization in diabetic patients with prior coronary surgery. J Am Coll Cardiol 40:1968–1975PubMedCrossRefGoogle Scholar
  15. 15.
    Antunes PE, de Oliveira JF, Antunes MJ (2008) Coronary surgery in patients with diabetes mellitus: a risk-adjusted study on early outcome. Eur J Cardiothorac Surg 34(2):370–375PubMedCrossRefGoogle Scholar
  16. 16.
    Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schnieder SH (2002) Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40:418–423PubMedCrossRefGoogle Scholar
  17. 17.
    Furnary AP, Gao G, Grunkemeier GL, Wu YX, Zerr KJ, Bookin SO, Floten HS, Starr A (2003) Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007–1021PubMedCrossRefGoogle Scholar
  18. 18.
    Ascione R, Rogers CA, Rajakaruna C, Angelini GD (2008) Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 118:113–123PubMedCrossRefGoogle Scholar
  19. 19.
    Furnary AP, Wu YX (2006) Clinical effects of hyperglycemia in the cardiac surgery population: the Portland diabetic project. Endocr Pract 12(Suppl 3):22–26PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • M. A. M. Wit
    • 1
  • M. de Mulder
    • 1
  • E. K. Jansen
    • 2
  • V. A. W. M. Umans
    • 1
  1. 1.Department of CardiologyMedical Centre AlkmaarAlkmaarThe Netherlands
  2. 2.Department of ThoraxsurgeryVU Medical CentreAmsterdamThe Netherlands

Personalised recommendations